An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

NCT06627335 · clinicaltrials.gov ↗

RECRUITING

Status

5621

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnancy Related
Atopic Dermatitis

Interventions

DRUG: Ruxolitinib Cream
DRUG: TCS

Sponsor

Incyte Corporation